Keywords: orphan, reports, revenue, dip, speciality, pharmaceutical, company
Orphan reports 2003 revenue dip of 4%
Article | 01 March 2004
Speciality pharmaceutical company Orphan Medical Inc has announced that its turnover for full-year 2003 fell 4% to $15.5 million compared to that achieved ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
